Abstract
Aims
To study the effects of smoking restrictions in Germany on coronary syndromes and their associated costs.
Methods and results
All German states implemented laws partially restricting smoking in the public and hospitality sectors between August 2007 and July 2008. We conducted a before-and-after study to examine trends for the hospitalization rate for angina pectoris and acute myocardial infarction (AMI) for an insurance cohort of 3,700,384 individuals 30 years and older. Outcome measures were hospitalization rates for coronary syndromes, and hospitalization costs. Mean age of the cohort was 56 years, and two-thirds were female. Some 2.2 and 1.1% persons were hospitalized for angina pectoris and AMI, respectively, during the study period from January 2004 through December 2008. Law implementation was associated with a 13.3% (95% confidence interval 8.2, 18.4) decline in angina pectoris and an 8.6% (5.0, 12.2) decline in AMI after 1 year. Hospitalization costs also decreased significantly for the two conditions—9.6% (2.5, 16.6) for angina pectoris and 20.1% (16.0, 24.2) for AMI at 1 year following law implementation. Assuming the law caused the observed declines, it prevented 1,880 hospitalizations and saved 7.7 million Euros in costs for this cohort during the year following law implementation.
Conclusions
Partial smoking restrictions in Germany were followed by reductions in hospitalization for angina pectoris and AMI, declines that continued through 1 year following these laws and resulted in substantial cost savings. Strengthening the laws could further reduce morbidity and costs from acute coronary syndromes in Germany.
Similar content being viewed by others
References
Peto R, Lopez AD, Boreham J, Thun M, Heath C (1994) Mortality from smoking in developed countries 1950–2000. Indirect estimates from national vital statistics. Oxford University Press, Oxford
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364(9438):937–952
Gohlke H, Yusuf S (2007) Quantitating loss of life by smoking a single cigarette. Clin Res Cardiol 96(7):522–523
Sherif MA, Nienaber CA, Toelg R, Abdel-Wahab M, Geist V, Schneider S et al (2011) Impact of smoking on the outcome of patients treated with drug-eluting stents: 1-year results from the prospective multicentre German Drug-Eluting Stent Registry (DES.DE). Clin Res Cardiol 100(5):413–423
US Department of Health and Human Services (2006) The health consequences of involuntary exposure to tobacco: a report of the Surgeon General. US Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health
Glantz SA, Parmley WW (1995) Passive smoking and heart disease. Mechanisms and risk. JAMA 273(13):1047–1053
Law MR, Morris JK, Wald NJ (1997) Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ 315(7114):973–980
Sun YP, Zhu BQ, Sievers RE, Glantz SA, Parmley WW (1994) Metoprolol does not attenuate atherosclerosis in lipid-fed rabbits exposed to environmental tobacco smoke. Circulation 89(5):2260–2265
Zhu BQ, Sun YP, Sievers RE, Isenberg WM, Glantz SA, Parmley WW (1993) Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol 21(1):225–232
Hutchison SJ, Sudhir K, Sievers RE, Zhu BQ, Sun YP, Chou TM et al (1999) Effects of l-arginine on atherogenesis and endothelial dysfunction due to secondhand smoke. Hypertension 34(1):44–50
Kallio K, Jokinen E, Raitakari OT, Hamalainen M, Siltala M, Volanen I et al (2007) Tobacco smoke exposure is associated with attenuated endothelial function in 11-year-old healthy children. Circulation 115(25):3205–3212
Leone A, Balbarini A (2008) Exposure to passive smoking: a test to predict endothelial dysfunction and atherosclerotic lesions. Angiology 59(2):220–223
Elwood PC, Renaud S, Sharp DS, Beswick AD, O’Brien JR, Yarnell JW (1991) Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study. Circulation 83(1):38–44
Schmidt KG, Rasmussen JW (1984) Acute platelet activation induced by smoking. In vivo and ex vivo studies in humans. Thromb Haemost 51(2):279–282
Pope CA III, Burnett RT, Krewski D, Jerrett M, Shi Y, Calle EE et al (2009) Cardiovascular mortality and exposure to airborne fine particulate matter and cigarette smoke: shape of the exposure–response relationship. Circulation 120(11):941–948
Centers for Disease Control and Prevention (CDC) (2009) Reduced hospitalizations for acute myocardial infarction after implementation of a smoke-free ordinance–City of Pueblo, Colorado, 2002–2006. MMWR Morb Mortal Wkly Rep 57(51):1373–1377
Barnoya J, Glantz SA (2006) Cardiovascular effects of second-hand smoke help explain the benefits of smoke-free legislation on heart disease burden. J Cardiovasc Nurs 21(6):457–462
Barone-Adesi F, Vizzini L, Merletti F, Richiardi L (2006) Short-term effects of Italian smoking regulation on rates of hospital admission for acute myocardial infarction. Eur Heart J 27(20):2468–2472
Bartecchi C, Alsever RN, Nevin-Woods C, Thomas WM, Estacio RO, Bartelson BB et al (2006) Reduction in the incidence of acute myocardial infarction associated with a citywide smoking ordinance. Circulation 114(14):1490–1496
Cesaroni G, Forastiere F, Agabiti N, Valente P, Zuccaro P, Perucci CA (2008) Effect of the Italian smoking ban on population rates of acute coronary events. Circulation 117(9):1183–1188
Jones SC, Travers MJ, Hahn EJ, Robertson H, Lee K, Higbee C et al (2006) Secondhand smoke and indoor public spaces in Paducah, Kentucky. J Ky Med Assoc 104(7):281–288
Juster HR, Loomis BR, Hinman TM, Farrelly MC, Hyland A, Bauer UE et al (2007) Declines in hospital admissions for acute myocardial infarction in New York state after implementation of a comprehensive smoking ban. Am J Public Health 97(11):2035–2039
Khuder SA, Milz S, Jordan T, Price J, Silvestri K, Butler P (2007) The impact of a smoking ban on hospital admissions for coronary heart disease. Prev Med 45(1):3–8
Lemstra M, Neudorf C, Opondo J (2008) Implications of a public smoking ban. Can J Public Health 99(1):62–65
Pell JP, Haw S, Cobbe S, Newby DE, Pell AC, Fischbacher C et al (2008) Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med 359(5):482–491
Sargent RP, Shepard RM, Glantz SA (2004) Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study. BMJ 328(7446):977–980
Seo DC, Torabi MR (2007) Reduced admissions for acute myocardial infarction associated with a public smoking ban: matched controlled study. J Drug Educ 37(3):217–226
Bonetti PO, Trachsel LD, Kuhn MU, Schulzki T, Erne P, Radovanovic D et al (2011) Incidence of acute myocardial infarction after implementation of a public smoking ban in Graubunden, Switzerland: two year follow-up. Swiss Med Wkly 141:w13206
Herman PM, Walsh ME (2011) Hospital admissions for acute myocardial infarction, angina, stroke, and asthma after implementation of Arizona’s comprehensive statewide smoking ban. Am J Public Health 101(3):491–496
Naiman A, Glazier RH, Moineddin R (2010) Association of anti-smoking legislation with rates of hospital admission for cardiovascular and respiratory conditions. CMAJ 182(8):761–767
Sims M, Maxwell R, Bauld L, Gilmore A (2010) Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction. BMJ 340:c2161
Villalbi JR, Sanchez E, Benet J, Cabezas C, Castillo A, Guarga A et al (2011) The extension of smoke-free areas and acute myocardial infarction mortality: before and after study. BMJ Open 1(1):000067
Lightwood JM, Glantz SA (2009) Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke. Circulation 120(14):1373–1379
Meyers DG, Neuberger JS, He J (2009) Cardiovascular effect of bans on smoking in public places: a systematic review and meta-analysis. J Am Coll Cardiol 54(14):1249–1255
Andersohn F, Schlattmann P, Roll S, Muller-Riemenschneider F, Binting S, Willich SN (2010) Regional variation of mortality from ischemic heart disease in Germany from 1998 to 2007. Clin Res Cardiol 99(8):511–518
Müller S, Kraus L, Piontek D, Pabst A (2011) Changes in exposure to secondhand smoke and smoking behavior. Sucht 56(5):3–373
Bickel PJ (2001) Mathematical statistics, 2nd edn. Prentice-Hall, Upper Saddle River, NJ
Fichtenberg CM, Glantz SA (2002) Effect of smoke-free workplaces on smoking behaviour: systematic review. BMJ 325(7357):188
Lampert M, List SM (2010) Tabak-Zahlen und Fakten zum Konsum. In: Deutsche Hauptstelle für Suchtfragen (ed) Jahrbuch Sucht 2010. Neuland, Geesthacht, pp 48–68
Schuler J, Maier B, Behrens S, Thimme W (2006) Present treatment of acute myocardial infarction in patients over 75 years—data from the Berlin Myocardial Infarction Registry (BHIR). Clin Res Cardiol 95(7):360–367
Tebbe U, Messer C, Stammwitz E, The GS, Dietl J, Bischoff KO et al (2007) Reduction of in-hospital mortality and improved secondary prevention after acute myocardial infarction. First results from the registry of secondary prevention after acute myocardial infarction (SAMI). Dtsch Med Wochenschr 132(30):1559–1566
The Joint European Society of Cardiology/American College of Cardiology Committee (2000) Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 21(18):1502–1513
Alpert JS, Thygesen K, Antman E, Bassand JP (2000) Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36(3):959–969
Gu YL, Voors AA, Zijlstra F, Hillege HL, Struck J, Masson S et al (2011) Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction. Clin Res Cardiol 100(12):1069–1076
Kurz K, Giannitsis E, Becker M, Hess G, Zdunek D, Katus HA (2011) Comparison of the new high sensitive cardiac troponin T with myoglobin, h-FABP and cTnT for early identification of myocardial necrosis in the acute coronary syndrome. Clin Res Cardiol 100(3):209–215
Meiser F (2008) Effect of the modified definition of the myocardial infarct using troponin for diagnosis, therapy, and process of NSTEMI in clinical daily routine in Germany [Einfluss der geänderten Definition des Myokardinfarktes unter Berücksichtigung der Troponine auf Diagnose, Therapie und Verlauf des NSTEMI im klinischen Alltag in Deutschland]. Doctoral thesis, University of Heidelberg, Heidelberg
IOM (Institute of Medicine) (2010) Secondhand smoke exposure and cardiovascular effects: making sense of the evidence. The National Academy Press, Washington, DC
Acknowledgments
Deutsche Angestellten-Krankenkasse (DAK), a German health insurance firm, provided the data for the analysis and some funding to support the data analysis. Dr. Sargent receives funding from the National Institutes of Health (CA 77026).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sargent, J.D., Demidenko, E., Malenka, D.J. et al. Smoking restrictions and hospitalization for acute coronary events in Germany. Clin Res Cardiol 101, 227–235 (2012). https://doi.org/10.1007/s00392-011-0385-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-011-0385-1